Dr. Everett Cordie Cooper Iii, M.D. Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: Chs-005, Kennedy Space Center, FL 32899 Phone: 321-861-8638 |
News Archive
The artificial lower limbs of double-amputee Olympic hopeful Oscar Pistorius give him a clear and major advantage over his competition, taking 10 seconds or more off what his 400-meter race time would be if his prosthesis behaved like intact limbs.
Final results of the randomized intergroup EORTC, LYSA (Lymphoma Study Association), FIL (Fondazione Italiana Linfomi) H10 trial presented at the 13th International Conference on Malignant Lymphoma in Lugano, Switzerland, on 19 June 2015 show that early FDG-PET ( 2-deoxy-2[F-18]fluoro-D-glucose positron emission tomography) adapted treatment improves the outcome of early FDG-PET-positive patients with stages I/II Hodgkin lymphoma.
Presidio Pharmaceuticals, Inc. today announced progress with its HCV antiviral drug discovery and development programs. A primary company objective is to advance multiple potent and safe inhibitors that target multiple HCV proteins and provide pan-genotypic coverage, as we believe such combination therapies will more adequately address the global medical need in the future.
The Division of Transplantation in the Department of Surgery at Thomas Jefferson University Hospital (TJUH) has started a live donor liver transplant program. Live donor liver transplantation (LDLT) is a procedure in which a living person donates a portion of his or her liver to another person. Combined, the two operations typically take about 12 hours. Since the program began in summer 2010, three patients and their donors have successfully undergone the procedure.
Interleukin Genetics, Inc. today announced that it has received commitments from certain institutional investors to purchase approximately $5.3 million of securities in a registered direct offering.
› Verified 1 days ago